Search
for
Sort by
Research 61–90 of 1000+
- An Update of Congenital Adrenal Hyperplasia
- Nonclassic adrenal hyperplasia
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- PCOS in Adolescence and Type 2 Diabetes
- Female Antiandrogens
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Updates on Hirsutism: A Narrative Review
- Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region
- Polycystic Ovary Syndrome
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Evaluation and treatment of male and female pattern hair loss
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Steroid Hormones
- Diagnosis and treatments of hirsutism: where are we?
- PCOS in adolescents
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- The effects of narrowbands of visible light upon some skin disorders: a review
- Diagnostic approach to low‐renin hypertension
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.